The prostate-specific antigen (PSA) can be measured in the blood to screen for PCA and can also be used in immunohistochemistry (IHC) to help distinguish between prostatic UC and PCA and is thus considered a reliable biomarker in human medicine [16]. The gene discussed is KLK3; the disease is posterior cortical atrophy.